Skip to main content

Table 1 Patient characteristics and results of EAT measurements

From: Measurement of epicardial adipose tissue using non-contrast routine chest-CT: a consideration of threshold adjustment for fatty attenuation

 

Total

Plaque ( +)

Plaque ( −)

P value

N

83

34

49

 

Age

55.3 ± 7.6

57.0 ± 9.0

54.2 ± 6.4

0.097

BMI

24.5 ± 2.9

24.9 ± 2.9

24.1 ± 2.8

0.221

Gender (Male)

46(55.4)

22(64.7)

24(49.0)

0.156

Hypertension (Yes)

41(49.4)

24(70.6)

17(34.7)

0.001*

Diabetes mellitus (Yes)

42(50.6)

20(58.8)

22(44.9)

0.212

Dyslipidemia (Yes)

37(44.6)

19(55.9)

18(36.7)

0.084

Calcified plaque

\

24(70.6)

\

 

Non-calcified plaque

\

10(29.4)

\

 

EV (cm3)

99.8 ± 37.9

115.6 ± 44.1

88.9 ± 28.6

0.003*

EVN30 (cm3)

115.0 ± 41.8

131.2 ± 49.6

103.7 ± 31.2

0.008*

EVN40 (cm3)

103.1 ± 39.9

118.8 ± 47.6

92.2 ± 29.4

0.006*

EVN45 (cm3)

98.0 ± 38.9

112.9 ± 46.6

87.6 ± 28.6

0.009*

mEA (HU)

 − 78.8 ± 4.1

 − 79.5 ± 3.8

 − 78.3 ± 4.2

0.204

mEAN30 (HU)

 − 78.8 ± 4.3

 − 80.0 ± 4.4

 − 78.0 ± 4.0

0.030*

mEAN40 (HU)

 − 84.0 ± 3.6

 − 84.8 ± 3.9

 − 83.4 ± 3.3

0.092

mEAN45 (HU)

 − 86.2 ± 3.3

 − 87.0 ± 3.5

 − 85.7 ± 3.0

0.075

  1. Data are shown as mean ± SD or number (%)
  2. EAT Epicardial adipose tissue; mEA mean EAT attenuation; EV EAT volume; Threshold of N30 (− 190HU, − 30HU), N40: (− 190HU, − 40HU); N45: (− 190HU, − 45HU)
  3. *P value < 0.05 was considered statistically significant